Latent Tuberculosis: Challenges in Diagnosis and Treatment, Perspectives, and the Crucial Role of Biomarkers

被引:0
作者
Jayanthi Palanivel
Vignesh Sounderrajan
T. Thangam
Sudhanarayani S. Rao
Shakila Harshavardhan
Krupakar Parthasarathy
机构
[1] Sathyabama Institute of Science and Technology,Centre for Drug Discovery and Development
[2] Madurai Kamaraj University,Department of Molecular Microbiology, School of Biotechnology
来源
Current Microbiology | 2023年 / 80卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tuberculosis (TB) is the major cause of morbidity and mortality globally, which is caused by a single infectious agent Mycobacterium tuberculosis. For years, many TB control programmes are established for effective diagnosis and treatment of active TB cases, but these approaches alone are insufficient for TB eradication. This review aims to discourse on the crucial management of latent tuberculosis infection. This review will first summarize the current status, and methods for diagnosing latent tuberculosis then describes the challenges involved in the diagnosis and treatment of latent tuberculosis, and finally encounters the purpose of biomarkers as predicting tool in latent tuberculosis.
引用
收藏
相关论文
共 359 条
[51]  
Periaswamy B(2021)Immune responses to Front Immunol 13 undefined-undefined
[52]  
De Sessions PF(2019) membrane-associated antigens including alpha-crystallin can potentially discriminate between latent infection and active tuberculosis disease J Infect 341 undefined-undefined
[53]  
Lin W(2015)Treatment of latent tuberculosis infection—an update EBioMedicine. 6 undefined-undefined
[54]  
Molton JS(2019)Use of isoniazid monotherapy in comparison to rifamycin-based regimen for the treatment of patients with latent tuberculosis: a systematic review Thorax. 14 undefined-undefined
[55]  
Naftalin CM(2021)Four months of rifampicin monotherapy for latent tuberculosis infection in children Bioengineered 45 undefined-undefined
[56]  
Paton NI(2021)Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis Front Immunol. 108 undefined-undefined
[57]  
Migliori GB(2022)Serum biomarker profile including CCL1, CXCL10, VEGF, and adenosine deaminase activity distinguishes active from remotely acquired latent tuberculosis Front Immunol 87 undefined-undefined
[58]  
Ong CW(2010)Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages BMJ. 252 undefined-undefined
[59]  
Petrone L(2016) infection Front Cell Infect Microbiol undefined undefined-undefined
[60]  
D'Ambrosio L(2015)A Genet Mol Res undefined undefined-undefined